| Title | Cancer Gene Therapy |
| Abbreviation | Cancer Gene Ther. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Molecular Biology (Q1); Molecular Medicine (Q1); Cancer Research (Q2) |
| h-index | 99 |
| Overall Rank/Ranking | 2372 |
| SCImago Journal Rank (SJR) | 1.457 |
| Impact Score | 4.96 |
| Publisher | Nature Publishing Group |
| Country | United Kingdom |
| ISSN | 14765500, 09291903 |
| Best Quartile | Q1 |
| Coverage History | 1994-2023 |
Cancer Gene Therapy publishes the results of laboratory investigations, preclinical studies, and clinical trials in the field of gene transfer/gene therapy as applied to cancer research. Types of articles published include original research articles, case reports, preliminary communications, review articles in the main fields of drug resistance/sensitivity, gene therapy, tumor suppressor and anti-oncogene therapy, cytokine/tumor immunotherapy, etc., industry perspective, and letters to the editor.
Cancer Gene Therapy is a journal covering the technologies/fields/categories related to Molecular Biology (Q1); Molecular Medicine (Q1); Cancer Research (Q2). It is published by Nature Publishing Group. The overall rank of Cancer Gene Therapy is 2372. According to SCImago Journal Rank (SJR), this journal is ranked 1.457. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 99. The best quartile for this journal is Q1.
The ISSN of Cancer Gene Therapy journal is 14765500, 09291903. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Cancer Gene Therapy is cited by a total of 1780 articles during the last 3 years (Preceding 2023).
The Impact IF 2023 of Cancer Gene Therapy is 4.96, which is computed in 2024 as per its definition. Cancer Gene Therapy IF is decreased by a factor of 1.33 and approximate percentage change is -21.14% when compared to preceding year 2022, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2023 of Cancer Gene Therapy is 4.96. If the same downward trend persists, Impact IF may fall in 2024 as well.
| Year | Impact IF |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 4.96 |
| 2022 | 6.29 |
| 2021 | 5.33 |
| 2020 | 4.74 |
| 2019 | 3.94 |
| 2018 | 4.70 |
| 2017 | 3.91 |
| 2016 | 3.60 |
| 2015 | 2.76 |
| 2014 | 2.83 |
Cancer Gene Therapy has an h-index of 99. It means 99 articles of this journal have more than 99 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Cancer Gene Therapy is 14765500, 09291903. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Cancer Gene Therapy is 2372. According to SCImago Journal Rank (SJR), this journal is ranked 1.457. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 1.457 |
| 2022 | 1.384 |
| 2021 | 1.207 |
| 2020 | 1.535 |
| 2019 | 0.930 |
| 2018 | 1.233 |
| 2017 | 1.359 |
| 2016 | 1.098 |
| 2015 | 1.014 |
| 2014 | 0.930 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 2372 |
| 2022 | 2440 |
| 2021 | 3029 |
| 2020 | 2185 |
| 2019 | 4807 |
| 2018 | 3183 |
| 2017 | 2718 |
| 2016 | 3822 |
| 2015 | 4363 |
| 2014 | 4782 |
Cancer Gene Therapy is published by Nature Publishing Group. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 1994-2023. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Cancer Gene Therapy is Cancer Gene Ther.. This abbreviation ('Cancer Gene Ther.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Molecular Biology (Q1); Molecular Medicine (Q1); Cancer Research (Q2), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Cancer Gene Therapy latest impact IF is 4.96. It's evaluated in the year 2023. The highest and the lowest impact IF or impact score of this journal are 6.29 (2022) and 2.76 (2015), respectively, in the last 10 years. Moreover, its average IS is 4.31 in the previous 10 years.
The Cancer Gene Therapy has an SJR (SCImago Journal Rank) of 1.457, according to the latest data. It is computed in the year 2024. In the past 10 years, this journal has recorded a range of SJR, with the highest being 1.535 in 2020 and the lowest being 0.930 in 2019. Furthermore, the average SJR of the Cancer Gene Therapy over the previous 10-year period stands at 4.31.
The latest h-index of the Cancer Gene Therapy is 99.
The Cancer Gene Therapy is published by the Nature Publishing Group, with its country of publication being the United Kingdom.
The Cancer Gene Therapy is currently ranked 2372 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 10 years, this journal has experienced varying rankings, reaching its highest position of 2185 in 2020 and its lowest position of 4807 in 2019.
The standard ISO4 abbreviation for the Cancer Gene Therapy is Cancer Gene Ther..
Cancer Gene Therapy is classified as a journal that the Nature Publishing Group publishes.
The Cancer Gene Therapy encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Cancer Gene Therapy is assigned the following International Standard Serial Numbers (ISSN): 14765500, 09291903.
The best quartile for the Cancer Gene Therapy is Q1 (2023).
The Cancer Gene Therapy coverage history can be summarized as follows: 1994-2023.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Journal of Business Economics and Management | journal | 9513 | Vilnius Gediminas Technical University | 48 | 3.30 |
| Criminal Justice Review | journal | 12054 | SAGE Publications Inc. | 42 | 1.10 |
| International Journal of Applied Linguistics | journal | 6241 | Wiley-Blackwell Publishing Ltd | 53 | 1.91 |
| World Englishes | journal | 3418 | Wiley-Blackwell | 64 | 1.64 |
| Modern Language Journal | journal | 1100 | Wiley-Blackwell | 112 | 3.93 |
| Rinsan Shikenj Oha/Journal of the Hokkaido Forest Products Research Institute | journal | 27272 | Hoikkaido Forest Products Research Institute | 4 | 0.00 |
| Biological Procedures Online | journal | 4092 | BioMed Central Ltd | 48 | 3.54 |
| Journal of Sociology | journal | 5238 | SAGE Publications Ltd | 62 | 2.22 |
| Nigerian journal of medicine : journal of the National Association of Resident Doctors of Nigeria | journal | 25905 | National Association of Resident Doctors of Nigeria | 25 | 0.00 |
| International Journal of Pest Management | journal | 13414 | Taylor and Francis Ltd. | 54 | 1.40 |
| Year | Impact Score (IS) |
|---|---|
| 2024/2025 | Coming Soon |
| 2023 | 4.96 |
| 2022 | 6.29 |
| 2021 | 5.33 |
| 2020 | 4.74 |
| 2019 | 3.94 |
| 2018 | 4.70 |
| 2017 | 3.91 |
| 2016 | 3.60 |
| 2015 | 2.76 |
| 2014 | 2.83 |
